These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19091559)

  • 1. Identification and structure-activity relationships of ortho-biphenyl carboxamides as potent Smoothened antagonists inhibiting the Hedgehog signaling pathway.
    Peukert S; Jain RK; Geisser A; Sun Y; Zhang R; Bourret A; Carlson A; Dasilva J; Ramamurthy A; Kelleher JF
    Bioorg Med Chem Lett; 2009 Jan; 19(2):328-31. PubMed ID: 19091559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides as highly potent smoothened antagonists.
    Muraglia E; Ontoria JM; Branca D; Dessole G; Bresciani A; Fonsi M; Giuliano C; Llauger Bufi L; Monteagudo E; Palumbi MC; Torrisi C; Rowley M; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5283-8. PubMed ID: 21802943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel hedgehog antagonists from cell-based screening: Isosteric modification of p38 bisamides as potent inhibitors of SMO.
    Yang B; Hird AW; Russell DJ; Fauber BP; Dakin LA; Zheng X; Su Q; Godin R; Brassil P; Devereaux E; Janetka JW
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4907-11. PubMed ID: 22704236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing PXR liabilities of phthalazine-based hedgehog/smoothened antagonists using novel pyridopyridazines.
    Kaizerman JA; Aaron W; An S; Austin R; Brown M; Chong A; Huang T; Hungate R; Jiang B; Johnson MG; Lee G; Lucas BS; Orf J; Rong M; Toteva MM; Wickramasinghe D; Xu G; Ye Q; Zhong W; McMinn DL
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4607-10. PubMed ID: 20594845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity.
    Miller-Moslin K; Peukert S; Jain RK; McEwan MA; Karki R; Llamas L; Yusuff N; He F; Li Y; Sun Y; Dai M; Perez L; Michael W; Sheng T; Lei H; Zhang R; Williams J; Bourret A; Ramamurthy A; Yuan J; Guo R; Matsumoto M; Vattay A; Maniara W; Amaral A; Dorsch M; Kelleher JF
    J Med Chem; 2009 Jul; 52(13):3954-68. PubMed ID: 19469545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of N-[(1-aryl-1H-indazol-5-yl)methyl]amides derivatives as smoothened antagonists for inhibition of the hedgehog pathway.
    Dessole G; Branca D; Ferrigno F; Kinzel O; Muraglia E; Palumbi MC; Rowley M; Serafini S; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4191-5. PubMed ID: 19540115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hedgehog pathway and pancreatic cancer.
    Hidalgo M; Maitra A
    N Engl J Med; 2009 Nov; 361(21):2094-6. PubMed ID: 19923581
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists.
    Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1426-31. PubMed ID: 24491459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule inhibitors of the hedgehog signaling pathway for the treatment of cancer.
    Yun JI; Kim HR; Park H; Kim SK; Lee J
    Arch Pharm Res; 2012 Aug; 35(8):1317-33. PubMed ID: 22941475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analogues of smoothened intracellular loops as potent inhibitors of Hedgehog pathway and cancer cell growth.
    Remsberg JR; Lou H; Tarasov SG; Dean M; Tarasova NI
    J Med Chem; 2007 Sep; 50(18):4534-8. PubMed ID: 17685505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acylthiourea, acylurea, and acylguanidine derivatives with potent hedgehog inhibiting activity.
    Solinas A; Faure H; Roudaut H; Traiffort E; Schoenfelder A; Mann A; Manetti F; Taddei M; Ruat M
    J Med Chem; 2012 Feb; 55(4):1559-71. PubMed ID: 22268551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a series of 4-[3-(quinolin-2-yl)-1,2,4-oxadiazol-5-yl]piperazinyl ureas as potent smoothened antagonist hedgehog pathway inhibitors.
    Ontoria JM; Bufi LL; Torrisi C; Bresciani A; Giomini C; Rowley M; Serafini S; Bin H; Hao W; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5274-82. PubMed ID: 21803580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second generation 2-pyridyl biphenyl amide inhibitors of the hedgehog pathway.
    Castanedo GM; Wang S; Robarge KD; Blackwood E; Burdick D; Chang C; Dijkgraaf GJ; Gould S; Gunzner J; Guichert O; Halladay J; Khojasteh C; Lee L; Marsters JC; Murray L; Peterson D; Plise E; Salphati L; de Sauvage FJ; Wong S; Sutherlin DP
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6748-53. PubMed ID: 20875741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics.
    Peukert S; Miller-Moslin K
    ChemMedChem; 2010 Apr; 5(4):500-12. PubMed ID: 20229564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GDC-0449-a potent inhibitor of the hedgehog pathway.
    Robarge KD; Brunton SA; Castanedo GM; Cui Y; Dina MS; Goldsmith R; Gould SE; Guichert O; Gunzner JL; Halladay J; Jia W; Khojasteh C; Koehler MF; Kotkow K; La H; Lalonde RL; Lau K; Lee L; Marshall D; Marsters JC; Murray LJ; Qian C; Rubin LL; Salphati L; Stanley MS; Stibbard JH; Sutherlin DP; Ubhayaker S; Wang S; Wong S; Xie M
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5576-81. PubMed ID: 19716296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of 1-piperazinyl-4-arylphthalazines as potent Smoothened antagonists.
    Lucas BS; Aaron W; An S; Austin RJ; Brown M; Chan H; Chong A; Hungate R; Huang T; Jiang B; Johnson MG; Kaizerman JA; Lee G; McMinn DL; Orf J; Powers JP; Rong M; Toteva MM; Uyeda C; Wickramasinghe D; Xu G; Ye Q; Zhong W
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3618-22. PubMed ID: 20493695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog pathway inhibitors: a patent review (2009--present).
    Hadden MK
    Expert Opin Ther Pat; 2013 Mar; 23(3):345-61. PubMed ID: 23294277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular dynamics approach to identify an oxysterol-based hedgehog pathway inhibitor.
    Dash RC; Maschinot CR; Hadden MK
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):168-177. PubMed ID: 27825830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclopropyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydroimid azo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 1.
    Malancona S; Altamura S; Filocamo G; Kinzel O; Hernando JI; Rowley M; Scarpelli R; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4422-8. PubMed ID: 21737272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and structure--activity-relationship of tetrahydrothiazolopyridine derivatives as potent smoothened antagonists.
    Ma H; Lu W; Sun Z; Luo L; Geng D; Yang Z; Li E; Zheng J; Wang M; Zhang H; Yang S; Zhang X
    Eur J Med Chem; 2015 Jan; 89():721-32. PubMed ID: 25462278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.